Publications by authors named "He-Kui Lan"

Background: Treatment outcomes for acute promyelocytic leukemia (APL) have improved with all-trans-retinoic acid and arsenic trioxide, yet relapse remains a concern, especially in pediatric patients. The prognostic value of minimal residual disease (MRD) post-induction and the impact of arsenic levels during induction on MRD are not fully understood.

Objectives: To evaluate the relationship between post-induction MRD levels and relapse-free survival (RFS) in pediatric APL patients, and to investigate the correlation between blood arsenic concentration levels during induction therapy and MRD status.

View Article and Find Full Text PDF
Article Synopsis
  • Realgar-Indigo Naturalis Formula (RIF), a traditional Chinese medicine, has shown effectiveness in treating adult acute promyelocytic leukemia (APL), but its efficacy and safety in children had not been studied.
  • A multicenter trial involving 176 pediatric patients compared RIF to intravenous arsenic trioxide (ATO), focusing on event-free survival (EFS) and treatment-related complications.
  • Results after 6 years indicated a high EFS of 97.6% in both groups, but the RIF group experienced shorter hospital stays, fewer infections, and potentially less cardiac toxicity, suggesting RIF could be a viable treatment alternative for pediatric APL.
View Article and Find Full Text PDF

Objective: To verify the pathogenesis in Chinese and to investigate the genetic rule of X-linked lymphoproliferative disease (XLP) therein.

Methods: The case history of a proband of XLP, male, aged 1 year and 5 months, who died 40 days after hospitalization, was reviewed. Fourteen his family members were interviewed for the development history, anamnesis, and underwent physical examination.

View Article and Find Full Text PDF

Objective: Allogeneic marrow transplantation is a curative therapy for thalassemia, but no more than 30% of patients have HLA-indentical sibling marrow donor. The selection of alternative donors of unrelative marrow and the study on the probability of treating thalassemia major with unrelated donor bone marrow transplantation are of importance.

Methods: Nine children with thalassemia were included in the study, and their gene mutational type were homozygote of thalassemia and double heterozygote, respectively.

View Article and Find Full Text PDF

Our project is designed to clone a 1.3kb gene fragment of telomerase catalytic subunit gene which contains seven reverse transcriptase motifs and specific region with conserved sequence termed "T motif". The gene fragment was amplified by PCR and was inserted into expression vector pET28-b.

View Article and Find Full Text PDF